Understanding Immune Responses in Alcoholic Hepatitis

This observational study aims to understand how the body's immune cells, specifically Peripheral Blood Mononuclear Cells (PBMCs), respond in people with alcoholic hepatitis, heavy drinkers without liver disease, and healthy individuals. Researchers will collect a 50-milliliter blood sample from participants to measure mitochondrial respiration (how cells produce energy). This will help them compare these responses across the different groups. You may be eligible if you are between 21 and 65 years old and have been diagnosed with alcoholic hepatitis, or if you are a heavy drinker without liver disease, or a healthy control. The study plans to enroll 30 participants.

Study design
This is an observational study with an unclear status, planning to enroll 30 participants.
What's involved
You would have a single blood draw of 50 milliliters.
Compensation
Not stated in the trial record.
Follow-up
Mitochondrial respiration will be measured at 1 day after the blood draw.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04088370

Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis

Recruiting
Not specifiedAges 21–65Observational
The Cleveland Clinic
~30 participants
Updated 2025-11-25 on ClinicalTrials.gov
What's tested:Blood Draw

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Quantify mitochondrial respiration
Measured over 1 day
Alcoholic Hepatitis
1 sites across 1 states
Ohio1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

inability or unwillingness to sign informed consent
cancer
autoimmune disease that in the opinion of the PI will confound study data
INR \< 1.4
total bilirubin levels must \<3
no prior history of known alcoholic liver disease
absence of hepatosplenomegaly (from physical examination or radiographic imaging) or stigmata of liver disease.
  • Quantify mitochondrial respiration1 day

    Mitochondrial Respiration will be quantified by using a standard substrate, uncoupler, inhibitor titration protocol using high resolution respirometry